GDNF and glioma: The discovery of glial cell line-derived neurotrophic factor (GDNF) as a secretion product from the rat B49 glioma cell line in 1993 heralded the arrival of a powerful promotor of dopaminergic cell survival with enormous potential for treating Parkinson’s disease (PD).